Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1989 Dec;86(23):9427-30.
doi: 10.1073/pnas.86.23.9427.

Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant

Affiliations
Case Reports

Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant

J A Trofatter et al. Proc Natl Acad Sci U S A. 1989 Dec.

Abstract

Pelizaeus-Merzbacher disease (PMD) is a human X chromosome-linked dysmyelination disorder of the central nervous system for which the genetic defect has not yet been established. The jimpy mutation jp of the mouse is an X chromosome-linked disorder of myelin formation. The mutation is at an intron/exon splice site in the mouse gene for proteolipid protein (PLP). With the jimpy mouse mutation as a precedent, we focused our attention on the human PLP gene, which is found at Xq22. The polymerase chain reaction was used to amplify the exons of the PLP gene of an affected male from a large Indiana PMD kindred. DNA sequencing showed a C----T transition at nucleotide 40 of the second exon. An affected third cousin also showed this sequence variation, while two unaffected male relatives (sons of an obligate carrier female) had the normal cytidine nucleotide. Allele-specific oligonucleotides were used to generate data for linkage studies on the above mentioned PMD kindred. Our results show tight linkage (theta = 0) of PMD to PLP with a lod (logarithm of odds) score of 4.62. In six other unrelated PMD kindreds, only the normal-sequence oligonucleotide hybridized, which indicates genetic heterogeneity. The radical nature of the predicted amino acid change (proline to leucine), suggests that the PMD-causing defect may have been delineated in one kindred.

PubMed Disclaimer

References

    1. J Child Neurol. 1986 Jul;1(3):233-9 - PubMed
    1. Ann Neurol. 1987 Feb;21(2):159-70 - PubMed
    1. FEBS Lett. 1987 Nov 2;223(2):417-21 - PubMed
    1. J Neurochem. 1987 Dec;49(6):1873-7 - PubMed
    1. J Neurosci Res. 1987;18(3):383-94 - PubMed

Publication types